AbbVie Hails Humira’s Resistance To US Competition

Adalimumab Originator Does Better Than Expected Against Biosimilar Pressure In Q2

 
• By David Wallace
  
Abstract image of man pushing back against dominoes
Humira is standing up to biosimilar competition • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products